Fig. 2From: Risk factors for erlotinib-induced hepatotoxicity: a retrospective follow-up studyKaplan-Meier curve of time to erlotinib-induced hepatotoxicity comparing patients with and without concomitant use of CYP3A4 inducersBack to article page